Literature DB >> 18206572

Supplements and the endocrine system in athletes.

Luigi Di Luigi1.   

Abstract

In the world of athletes' nutrition, there are many ethical concerns, because there is the suspicion that in practice, large doses of supplements in athletes are not taken for nutritional purposes. It is beyond the scope of this article to highlight the possible roles of supplements or methods of supplementation in the improvement of athletic performance in elite athletes. Instead, the author briefly reviews some of the substances taken by athletes, with particular attention to their mechanisms of action and the pathways involved. Very often, the effects of many supplements are hormone-related, or supplements influence hormone secretion. Examples of possible links between "supplements or ergogenic compounds" and the endocrine/metabolic system are addressed.

Mesh:

Substances:

Year:  2008        PMID: 18206572     DOI: 10.1016/j.csm.2007.09.003

Source DB:  PubMed          Journal:  Clin Sports Med        ISSN: 0278-5919            Impact factor:   2.182


  14 in total

1.  Supra-physiological rhGH administration induces gender-related differences in the hypothalamus-pituitary-thyroid (HPT) axis in healthy individuals.

Authors:  P Sgrò; M Sansone; A Parisi; A Sartorio; A Sansone; F Romanelli; A Lenzi; L Di Luigi
Journal:  J Endocrinol Invest       Date:  2016-05-26       Impact factor: 4.256

2.  Short-term, supra-physiological rhGH administration induces transient DNA damage in peripheral lymphocytes of healthy women.

Authors:  C Fantini; P Sgrò; M Pittaluga; A de Perini; I Dimauro; A Sartorio; D Caporossi; L Di Luigi
Journal:  J Endocrinol Invest       Date:  2017-02-16       Impact factor: 4.256

3.  The phosphodiesterase 5 inhibitor tadalafil regulates lipidic homeostasis in human skeletal muscle cell metabolism.

Authors:  F Marampon; C Antinozzi; C Corinaldesi; G B Vannelli; E Sarchielli; S Migliaccio; L Di Luigi; A Lenzi; C Crescioli
Journal:  Endocrine       Date:  2017-08-07       Impact factor: 3.633

4.  Influence of the PDE5 inhibitor tadalafil on redox status and antioxidant defense system in C2C12 skeletal muscle cells.

Authors:  Guglielmo Duranti; Roberta Ceci; Paolo Sgrò; Stefania Sabatini; Luigi Di Luigi
Journal:  Cell Stress Chaperones       Date:  2017-03-11       Impact factor: 3.667

Review 5.  Sport and male sexuality.

Authors:  P Sgrò; L Di Luigi
Journal:  J Endocrinol Invest       Date:  2017-03-22       Impact factor: 4.256

Review 6.  The use of prohibited substances for therapeutic reasons in athletes affected by endocrine diseases and disorders: the therapeutic use exemption (TUE) in clinical endocrinology.

Authors:  L Di Luigi; F Pigozzi; P Sgrò; L Frati; A Di Gianfrancesco; M Cappa
Journal:  J Endocrinol Invest       Date:  2019-11-16       Impact factor: 4.256

7.  Testosterone responses to standardized short-term sub-maximal and maximal endurance exercises: issues on the dynamic adaptive role of the hypothalamic-pituitary-testicular axis.

Authors:  P Sgrò; F Romanelli; F Felici; M Sansone; S Bianchini; C F Buzzachera; C Baldari; L Guidetti; F Pigozzi; A Lenzi; L Di Luigi
Journal:  J Endocrinol Invest       Date:  2014-01-08       Impact factor: 4.256

Review 8.  Acute kidney injury due to anabolic steroid and vitamin supplement abuse: report of two cases and a literature review.

Authors:  Elizabeth F Daher; Geraldo B Silva Júnior; Anaiara L Queiroz; Lysiane M A Ramos; Silvia Q Santos; Dulce M S Barreto; Antonio Augusto C Guimarães; Célio A Barbosa; Luciano M Franco; Régia M S V Patrocínio
Journal:  Int Urol Nephrol       Date:  2009-04-23       Impact factor: 2.370

9.  Consumption and biochemical impact of commercially available plant-derived nutritional supplements. An observational pilot-study on recreational athletes.

Authors:  Paolo Borrione; Marta Rizzo; Federico Quaranta; Emanuela Ciminelli; Federica Fagnani; Attilio Parisi; Fabio Pigozzi
Journal:  J Int Soc Sports Nutr       Date:  2012-06-19       Impact factor: 5.150

10.  Opinion controversy to chromium picolinate therapy's safety and efficacy: ignoring 'anecdotes' of case reports or recognising individual risks and new guidelines urgency to introduce innovation by predictive diagnostics?

Authors:  Olga Golubnitschaja; Kristina Yeghiazaryan
Journal:  EPMA J       Date:  2012-10-07       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.